Tutorials
Pulmonx Corp logo

Pulmonx Corp

$ 22.19 -0.61 (-2.68%) 08:09 PM EST
P/E:
At Loss
P/B:
4.80
Market Cap:
$ 826.99M
Enterprise V:
$ 690.76M
Volume:
219.97K
Avg Vol (2M):
467.09K
Also Trade In:
Volume:
219.97K
Market Cap $:
826.99M
PE Ratio:
At Loss
Avg Vol (2-Month):
467.09K
Enterprise Value $:
690.76M
PB Ratio:
4.80
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Pulmonx Corp
NAICS : 334510 SIC : 3842
700 Chesapeake Drive, Redwood, CA, USA, 94063
Compare
Compare
CSII QTRX BFLY ZIMV AORT INGN UFPT TMDX ATEC CUTR ABT MDT SYK EW BSX SZSE:300760 DXCM ZBH STE ALGN
Traded in other countries / regions
4NI.Germany LUNG.USA
Description
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.
Name Current Vs Industry Vs History
Cash-To-Debt 6.27
Equity-to-Asset 0.81
Debt-to-Equity 0.15
Debt-to-EBITDA -0.51
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.52
Distress
Grey
Safe
Beneish M-Score -2.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 62.49
9-Day RSI 66.45
14-Day RSI 65.6
6-1 Month Momentum % -43.47
12-1 Month Momentum % -58.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.43
Quick Ratio 8.49
Cash Ratio 7.93
Days Inventory 455.04
Days Sales Outstanding 48.99
Days Payable 75.15

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.3

Financials (Next Earnings Date:2022-11-02 Est.)

LUNG's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:LUNG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 51.704
EPS (TTM) ($) -1.46
Beta 0
Volatility % 45.99
14-Day RSI 65.6
14-Day ATR ($) 1.526904
20-Day SMA ($) 18.59
12-1 Month Momentum % -58.71
52-Week Range ($) 13.7926 - 45.49
Shares Outstanding (Mil) 37.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pulmonx Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More